SCHEMBL24995754

SCHEMBL24995754

Nc1ccc(Oc2ccc3ncnn3c2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.42
PDE7A Q13946 2/20 0.39
SCN5A Q14524 1/20 0.39
JAK2 O60674 1/20 0.39
MPO P05164 1/20 0.37
TPO P07202 1/20 0.37
EPX P11678 1/20 0.37
LPO P22079 1/20 0.37
SLC6A4 P31645 5/20 0.35
HTR2A P28223 1/20 0.35
PNLIP P16233 1/20 0.34
BACE1 P56817 1/20 0.33
SLC6A2 P23975 4/20 0.33
SLC6A3 Q01959 4/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
NPC1 O15118 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879388 0.84 DYRK1A (0.42) DYRK1ASCN5AJAK2MEN1KMT2A
SCHEMBL1192681 0.84 DYRK1A (0.42) DYRK1ASCN5AJAK2MEN1KMT2A
SCHEMBL12524904 0.84 SCN5A (0.39) DYRK1ASCN5AJAK2SLC6A4HTR2A
SCHEMBL3484112 0.82 EGFR (0.38) PDE7AMPOTPOEPXLPO
SCHEMBL29887886 0.82 EGFR (0.38) PDE7AMPOTPOEPXLPO
SCHEMBL15703638 0.81 CYP2C19 (0.40) DYRK1ASCN5AJAK2HDAC1HDAC8
SCHEMBL12872522 0.80 ALDH1A1 (0.47) DYRK1ASCN5AMEN1KMT2ANPC1
SCHEMBL30879425 0.79 PDE7A (0.55) PDE7AMEN1KMT2ANPC1CYP3A4
SCHEMBL3483796 0.78 PDE7A (0.41) PDE7ASCN5AMPOTPOEPX
SCHEMBL23817200 0.76 CYP3A4 (0.33) DYRK1APDE7AJAK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980309-A Tricyclic fused pyrimidine compounds useful as HER2 inhibitors 百时美施贵宝公司 2024-05-03 CN disclosed
WO-2023015240-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-02-09 WO disclosed